Cytonix

Startups QuantaLife and Inostics join more established outfits RainDance Technologies and Life Technologies in exploring the digital PCR market, but all players will need to negotiate what is sure to be a complex intellectual property landscape.

Digital PCR may be on the verge of becoming nearly as ubiquitous as its predecessor, quantitative real-time PCR, thanks to the integration of empowering nanoscale and microfluidic technologies.

ABI's recently launched MeltDoctor HRM kits are among a series of moves that the company is making to expand its PCR business in the clinical market, an ABI official told GenomeWeb Daily News.

Life Technologies disclosed the acquisition in its second-quarter earnings release. It said that it bought the firm for its intellectual property related to its microfluidics-based digital polymerase chain reaction technology.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.